1. Academic Validation
  2. Hederagenin, a major component of Clematis mandshurica Ruprecht root, attenuates inflammatory responses in RAW 264.7 cells and in mice

Hederagenin, a major component of Clematis mandshurica Ruprecht root, attenuates inflammatory responses in RAW 264.7 cells and in mice

  • Int Immunopharmacol. 2015 Dec;29(2):528-537. doi: 10.1016/j.intimp.2015.10.002.
Chul Won Lee 1 Sang Mi Park 2 Rongjie Zhao 3 Chu Lee 4 Wonjoo Chun 5 Yonghae Son 5 Sung Hun Kim 6 Ji Yun Jung 2 Kyung Hwan Jegal 2 Il Je Cho 2 Sae Kwang Ku 2 Young Woo Kim 2 Seong A Ju 7 Sang Chan Kim 8 Won G An 9
Affiliations

Affiliations

  • 1 Institute of Marine BioTechnology, Pusan National University, Busan 609-735, South Korea; MRC-GHF, College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, South Korea.
  • 2 MRC-GHF, College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, South Korea.
  • 3 Department of Pharmacology, Mudanjiang Medical University, Mudanjiang 157011, China. Electronic address: [email protected].
  • 4 Aquaculture Industry Division, NFRDI, Gangneung, South Korea.
  • 5 Institute of Marine BioTechnology, Pusan National University, Busan 609-735, South Korea.
  • 6 Dept. of Oriental Cuisine and Culinary Art, Yongsan University, Yangsan 626-870, South Korea.
  • 7 Biomedical Research Center, Ulsan University Hospital, College of Medicine, University of Ulsan, Ulsan 680-749, South Korea.
  • 8 MRC-GHF, College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, South Korea. Electronic address: [email protected].
  • 9 Institute of Marine BioTechnology, Pusan National University, Busan 609-735, South Korea; Division of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan 626-870, South Korea. Electronic address: [email protected].
Abstract

Clematis mandshurica Ruprecht root has been used in Asia as a traditional anti-inflammatory, analgesic, and antitumor agent. Its main active component is hederagenin, a naturally occurring triterpene, and in this study, we examined the anti-inflammatory effects of hederagenin in lipopolysaccharide-stimulated RAW 264.7 cells using an enzyme-linked immunosorbent assay, Western blot, and RT-PCR. In addition, its effects on acute inflammation in vivo were observed using a carrageenan-induced mouse hind paw edema assay. Furthermore, the changes on the histopathology and histomorphometry of hind paw skins were examined using carrageenan-treated mice. Treatment with hederagenin (10, 30 and 100μM) resulted in inhibited levels of protein expression of lipopolysaccharide-stimulated iNOS, COX-2, and NF-κB as well as production of NO, PGE2, TNF-α, IL-1β, and IL-6 induced by lipopolysaccharide. Consistent with these results, hederagenin also dose-dependently reduced the lipopolysaccharide-induced mRNA levels of iNOS and COX-2, and of the above-mentioned cytokines. Interestingly, results of the carrageenan-induced mouse hind paw edema assay showed an anti-edema effect of hederagenin. Furthermore, hederagenin (30mg/kg) inhibited the carrageenan-induced increases in skin thicknesses, infiltrated inflammatory cells, and mast cell degranulation. These results suggest that hederagenin may possess anti-inflammatory activities.

Keywords

Hederagenin; Histological examination; Inflammatory response; Mouse paw edema; Nuclear factor-kappa B.

Figures
Products